Cargando…
Nanotechnology-Based Vaccines for Allergen-Specific Immunotherapy: Potentials and Challenges of Conventional and Novel Adjuvants under Research
The increasing prevalence of allergic diseases demands efficient therapeutic strategies for their mitigation. Allergen-specific immunotherapy (AIT) is the only causal rather than symptomatic treatment method available for allergy. Currently, AIT is being administered using immune response modifiers...
Autores principales: | Johnson, Litty, Duschl, Albert, Himly, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349961/ https://www.ncbi.nlm.nih.gov/pubmed/32443671 http://dx.doi.org/10.3390/vaccines8020237 |
Ejemplares similares
-
The nanotopography of SiO(2) particles impacts the selectivity and 3D fold of bound allergens
por: Mills-Goodlet, Robert, et al.
Publicado: (2021) -
Surface Functionalization of Silica Nanoparticles: Strategies to Optimize the Immune-Activating Profile of Carrier Platforms
por: Punz, Benjamin, et al.
Publicado: (2022) -
Mechanistic insights into silica nanoparticle–allergen interactions on antigen presenting cell function in the context of allergic reactions
por: Johnson, Litty, et al.
Publicado: (2023) -
Adjuvants and Vaccines Used in Allergen-Specific Immunotherapy Induce Neutrophil Extracellular Traps
por: Karacs, Jasmine, et al.
Publicado: (2021) -
Vaccine Adjuvant Nanotechnologies
por: Barclay, T., et al.
Publicado: (2017)